Literature DB >> 1776509

Acute revascularization for progressing stroke.

A Ogawa1, T Yoshimoto, K Mizoi, T Sugawara, Y Sakurai, H Sato.   

Abstract

The effectiveness of acute stage vascular reconstruction in cases of progressing stroke is reported. The clinical material consists of 28 cases of progressing stroke in the anterior circulation upon which vascular reconstruction was performed. Following admission, brain protective substances (500 ml mannitol, 500 mg vitamin E, 500 mg phenytoin) and dextran, were administered to the patients, and induced hypertension was also performed. Changes in symptoms were then observed and vascular reconstruction was carried out in cases where symptoms progressed. The vascular lesion was on the internal carotid artery in 8 cases and on the middle cerebral artery in 20 cases. Complete disappearance of neurological symptoms was obtained in 12 cases, whereas only mild neurological symptoms remained but a return to normal social life was possible in 11 other cases. Symptoms remained in three cases and there were two fatalities. In a long-term follow-up study, there were no cases of aggravation of symptoms due to ischaemic stroke. Moreover, the reconstruction was judged as effective on the basis of cerebral blood flow and metabolism. We concluded that acute vascular reconstruction for progressing stroke under the administration of brain protective substances is effective in preventing the progression of neurological symptoms.

Entities:  

Mesh:

Year:  1991        PMID: 1776509     DOI: 10.1007/bf01405135

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  18 in total

1.  Treatment of progressing stroke.

Authors:  C H Millikan; F H McDowell
Journal:  Stroke       Date:  1981 Jul-Aug       Impact factor: 7.914

2.  Extracranial-intracranial (EC-IC) arterial bypass: past performance and current concepts.

Authors:  D S Samson; S Boone
Journal:  Neurosurgery       Date:  1978 Jul-Aug       Impact factor: 4.654

3.  Microsurgical vascular bypass for occlusive cerebrovascular disease; review of 100 cases.

Authors:  N Chater; J Popp
Journal:  Surg Neurol       Date:  1976-08

4.  Clinical experience with extra-intracranial arterial anastomosis in 65 cases.

Authors:  O Gratzl; P Schmiedek; R Spetzler; H Steinhoff; F Marguth
Journal:  J Neurosurg       Date:  1976-03       Impact factor: 5.115

5.  The protective effect of combined administration of anti-oxidants and perfluorochemicals on cerebral ischemia.

Authors:  J Suzuki; S Fujimoto; K Mizoi; M Oba
Journal:  Stroke       Date:  1984 Jul-Aug       Impact factor: 7.914

6.  XIV. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapy.

Authors:  E Genton; H J Barnett; W S Fields; M Gent; J C Hoak
Journal:  Stroke       Date:  1977 Jan-Feb       Impact factor: 7.914

7.  Experimental cerebral infarction. Part 3: Protective effect of mannitol in thalamic infarction in dogs.

Authors:  T Yoshimoto; T Sakamoto; T Watanabe; S Tanaka; J Suzuki
Journal:  Stroke       Date:  1978 May-Jun       Impact factor: 7.914

8.  Angiographical analysis of acute cerebral infarction followed by "cascade"-like deterioration of minor neurological deficits. What is progressing stroke?

Authors:  T Irino; M Watanabe; M Nishide; M Gotoh; T Tsuchiya
Journal:  Stroke       Date:  1983 May-Jun       Impact factor: 7.914

9.  Potential roles for early revascularization in patients with acute cerebral ischemia.

Authors:  H Batjer; B Mickey; D Samson
Journal:  Neurosurgery       Date:  1986-03       Impact factor: 4.654

10.  Acute cerebral revascularization.

Authors:  F G Diaz; J I Ausman; B Mehta; M Dujovny; R A de los Reyes; J Pearce; S Patel
Journal:  J Neurosurg       Date:  1985-08       Impact factor: 5.115

View more
  1 in total

1.  Superficial temporal artery--middle cerebral artery anastomosis for acute cerebral ischemia: the effect of small augmentation of blood flow.

Authors:  Y Yoshimoto; S Kwak
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.